Skip to main content
ARTRYA LIMITED logo

ARTRYA LIMITED — Investor Relations & Filings

Ticker · AYA ISIN · AU0000182412 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 322 across all filing types
Latest filing 2021-12-15 Regulatory Filings
Country AU Australia
Listing ASX AYA

About ARTRYA LIMITED

https://artrya.com

Artrya Limited is a medical technology company focused on the development of artificial intelligence solutions for the detection and management of coronary artery disease. The company's flagship platform, Artrya Salix, utilizes deep learning algorithms to automate the analysis of Computed Tomography Coronary Angiography (CTCA) scans. This technology is designed to assist clinicians by identifying and quantifying key markers of heart disease, including coronary artery stenosis and high-risk vulnerable plaque, which are often difficult to detect through manual review. By providing rapid, non-invasive, and objective assessments, the platform aims to improve diagnostic accuracy, streamline clinical workflows, and support early intervention strategies for patients at risk of major adverse cardiac events. The software integrates into existing clinical environments to provide point-of-care decision support for radiologists and cardiologists.

Recent filings

Filing Released Lang Actions
Artrya Update December 2021 3 pages 121.7KB
Regulatory Filings Classification · 95% confidence The document is a brief update letter addressed to shareholders, providing progress on product development, regulatory approvals, market entry, and commercial plans. It mentions the company's recent listing on the ASX and outlines milestones and future expectations. There are no detailed financial statements, comprehensive financial performance data, or formal report structures typical of Annual Reports (10-K), Interim Reports (IR), or Earnings Releases (ER). The document is relatively short (4656 characters) and reads as a corporate update or announcement rather than a formal report. It does not fit into categories like Board/Management changes, Capital updates, or Legal Proceedings. Given the nature of the content and length, it best fits the category of a Regulatory Filing (RNS), which serves as a general announcement or update that does not neatly fit into other specific categories.
2021-12-15 English
Cardiac imaging software company Artrya Lists on ASX 1
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 26 November 2021 regarding Artrya Limited's listing on the Australian Securities Exchange (ASX) following an initial public offering (IPO). It details the IPO completion, share issuance, market capitalization, and future growth plans. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is short (3241 characters) and serves as a formal announcement of a capital market event (IPO listing). This fits the Capital/Financing Update (CAP) category, which covers updates on company fundraising and capital structure changes such as IPOs. It is not an Annual Report, Earnings Release, or Regulatory Filing, nor is it a report publication announcement. Therefore, the correct classification is CAP with high confidence.
2021-11-25 English
Initial Director's Interest Notice - John Barrington AM 2 pages 58.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of a director, John Barrington AM, including shares and options held, with specifics on escrow periods. There is no financial performance data, earnings information, or management discussion. The content is focused on the director's personal shareholdings and interests in securities. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or holdings by company directors and executives. The document length is 2582 characters, which is typical for such notices. Therefore, the correct classification is DIRS (Director's Dealing).
2021-11-25 English
Initial Director's Interest Notice - John Konstantopoulos 2 pages 59.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and options held by the director and related parties. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions or holdings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director interests, confirming it is not a full report or announcement of a report. Therefore, the correct classification is DIRS.
2021-11-25 English
Initial Director's Interest Notice - Bernie Ridgeway 2 pages 59.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and options held directly or indirectly, and notes the director's appointment date. There is no financial performance data, earnings information, or report publication. The content is focused on disclosure of personal shareholdings and interests of a company director, which aligns with the definition of Director's Dealing filings. The document length is short and specific to director interests, confirming it is not a full report or announcement of a report. Therefore, the correct classification is Director's Dealing (DIRS).
2021-11-25 English
Notice of Initial Substantial Holder - John Barrington 2 pages 115.1KB
Major Shareholding Notification Classification · 100% confidence The document is an ASIC Form 603 titled 'Notice of initial substantial holder' under the Corporations Act 2001 Section 671B. It details the substantial shareholding of John Barrington in Artrya Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This form is a regulatory notification of a major shareholding event, specifically the initial substantial holder notice. It is not a financial report, earnings release, or management report. It fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length and content confirm it is a full notification rather than a brief announcement or certification, so MRQ is appropriate.
2021-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.